Edgewise Therapeutics, Inc. (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today presented at the 2026 ...
Deramiocel BLA for Duchenne muscular dystrophy under U.S. FDA review with PDUFA target action date of August 22, 2026Pivotal ...
Some public companies have links to artificial intelligence. Here's what the experts say about AI stocks and a list of the best-performing AI stocks right now. Many, or all, of the products featured ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results